Company / Interest Expense per Share
West Pharmaceutical Services Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.21
FY2025
5-year range
$0.11 / $0.22
FY2021-FY2025
Trend
-5.2%
vs FY2024
Sector context
#33 of 44
Health Care
What the data says
West Pharmaceutical Services's interest expense per share of $0.21 is lower than 75% of companies in the Health Care sector (FY2025). Interest Expense per Share has fluctuated over the past 10 years, ranging from $0.11 in FY2017 to $0.23 in FY2016.
Based on SEC 10-K filings.
0.21 in FY2025 with a 5-year CAGR of +13.0%.
Increased from $0.12 to $0.21 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +23.6%
- 5-Year CAGR
- +13.0%
- 10-Year CAGR
- -
Sector benchmark
-85.7% below sector average
Key checks
Key Insights
- In FY2025, interest expense per share decreased 5.2% year-over-year.
- Ranks #33 out of 44 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2016.
- Lowest interest expense per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.21 | -5.2% |
| FY2024 | $0.22 | +81.5% |
| FY2023 | $0.12 | +9.9% |
| FY2022 | $0.11 | -3.8% |
| FY2021 | $0.11 | +1.3% |
| FY2020 | $0.11 | -1.2% |
| FY2019 | $0.11 | +0.9% |
| FY2018 | $0.11 | +6.5% |
| FY2017 | $0.11 | -53.2% |
| FY2016 | $0.23 | -4.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026